Wolverine Trading, LLC Intercept Pharmaceuticals, Inc. Transaction History

Wolverine Trading, LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$12.53 - $21.71 $131,339 - $227,564	10,482 New	10,482 $141,000
Q3 2020 Nov 13, 2020	SELL	$39.09 - $53.44 $139,199 - $190,299	-3,561 Reduced 31.44%	7,765 $324,000
Q2 2020 Aug 13, 2020	SELL	$46.7 - $92.04 $482,691 - $951,325	-10,336 Reduced 47.71%	11,326 $529,000
Q1 2020 May 11, 2020	BUY	$48.35 - $118.68 $210,129 - $515,783	4,346 Added 25.1%	21,662 $1.41 Million
Q4 2019 Feb 12, 2020	SELL	$57.36 - $124.1 $1.8 Million - $3.89 Million	-31,328 Reduced 64.4%	17,316 $2.14 Million
Q3 2019 Nov 14, 2019	SELL	$58.69 - $80.46 $593,590 - $813,772	-10,114 Reduced 17.21%	48,644 $3.12 Million
Q2 2019 Aug 20, 2019	BUY	$77.77 - $120.68 $1.28 Million - $1.99 Million	16,454 Added 38.89%	58,758 $4.68 Million
Q1 2019 May 15, 2019	BUY	$91.83 - $120.68 $633,535 - $832,571	6,899 Added 19.49%	42,304 $4.73 Million
Q4 2018 Feb 14, 2019	BUY	$85.79 - $126.46 $975,003 - $1.44 Million	11,365 Added 47.28%	35,405 $3.33 Million
Q3 2018 Nov 14, 2018	SELL	$88.49 - $127.55 $1.99 Million - $2.87 Million	-22,522 Reduced 48.37%	24,040 $3.04 Million
Q1 2018 May 15, 2018	BUY	$52.72 - $67.25 $2.45 Million - $3.13 Million	46,562 New	46,562 $2.86 Million

1.04M

30K

5.9K

Ticker ICPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,127,400
Description
Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Wolverine Trading, LLC with notifications on news.